The once-hot Silicon Valley startup has seen its stock’s value decline 99% and is struggling to survive. That has put the ...

J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...

In a report released today, Peter Welford from Jefferies maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price ...

"I've watched and been a part of Illumina growing from a startup to one of the most important and innovative companies in the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

With vaccine hesitancy leading to a rise in measles cases, the FDA's approval of GlaxoSmithKline's venerable vaccine Priorix for sale in the US looks timely. Priorix was first launched in Europe ...

GlaxoSmithKline is investing in artificial intelligence (AI) with the hope of radically cutting the time and money needed to develop a drug. It has entered into an alliance with Exscientia ...

After hours: 2 October at 19:51 GMT-4 ...

Aditya Birla SL ELSS Tax Saver Fund (IDCW) 275.42 10,03,316 1.64 Aditya Birla SL ELSS Tax Saver Fund (G) 275.42 10,03,316 1.64 Aditya Birla SL ELSS Tax Saver Fund ...

Teva Pharmaceutical Industries Ltd. ADR-1.19% $20.05B ...